Senate Veterans Affairs Committee will hold ibogaine-specific hearings with Stanford researchers testifying before September 2026.

The US Senate Committee that oversees veterans healthcare will hold public hearings specifically about ibogaine for addiction treatment, with Stanford researchers presenting evidence. This happens because veterans are advocating for ibogaine access and senators need to understand both the promise and the recent cardiac safety concerns before they act.

Stanford ibogaine veteran signal is at 100% narrative strength. Today's competing cardiac papers actually create the perfect congressional hearing dynamic — safety versus access, with veterans as human testimony.